Score Overview
Jazz Pharmaceuticals PLC fundamental performance
Between 2020 and 2025, revenue grew from $ 2.36B to $ 4.26B and net income went from $ 238M to -$ 356M. Revenue increased in every one of those 5 years; net income in 4.
Across Jazz Pharmaceuticals PLC's full reported history, from 2007 to 2025, revenue grew from $ 65M to $ 4.26B and net income went from -$ 138M to -$ 356M. Revenue increased in 100% of the years measured; net income in 63%.
Jazz Pharmaceuticals PLC currently holds a 5-year HDB Score of 8.3 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 245.85 | — |
1 Year2025-08-13 | $ 117.12 | 109.91% |
5 Years2021-08-13 | $ 142.16 | 72.94% |
10 Years2016-08-12 | $ 136.56 | 80.03% |
All Time2007-06-01 | $ 17.73 | 13x |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | 10 Years2016-08-12 | All Time2007-06-01 |
|---|---|---|---|---|---|
| Price | $ 245.85 | $ 117.12 | $ 142.16 | $ 136.56 | $ 17.73 |
| Return | — | 109.91% | 72.94% | 80.03% | 13x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 4.60B | $ 940M | $ 2.19B |
| 2025 | $ 4.26B | -$ 356M | $ 2.44B |
| 2024 | $ 4.06B | $ 560M | $ 2.99B |
| 2023 | $ 3.83B | $ 414M | $ 1.62B |
| 2022 | $ 3.65B | -$ 224M | $ 881M |
| 2021 | $ 3.09B | -$ 328M | $ 591M |
| 2020 | $ 2.36B | $ 238M | $ 2.13B |
| 2019 | $ 2.16B | $ 523M | $ 1.07B |
| 2018 | $ 1.89B | $ 447M | $ 824M |
| 2017 | $ 1.61B | $ 487M | $ 601M |
| 2016 | $ 1.48B | $ 396M | $ 425M |
| 2015 | $ 1.32B | $ 329M | $ 988M |
| 2014 | $ 1.17B | $ 58M | $ 684M |
| 2013 | $ 872M | $ 216M | $ 636M |
| 2012 | $ 585M | $ 288M | $ 387M |
| 2011 | $ 272M | $ 124M | $ 157M |
| 2010 | $ 173M | $ 32M | $ 44M |
| 2009 | $ 128M | -$ 6M | $ 15M |
| 2008 | $ 67M | -$ 184M | $ 25M |
| IPO2007 | $ 65M | -$ 138M | $ 102M |
Explore beyond JAZZ
You're looking at Jazz Pharmaceuticals PLC. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
